Thailand’s top hospital for international patients, Bumrungrad International, has launched a new cancer treatment with comprehensive genomic testing. This new cancer treatment comes after Bumrungrad moved into personalised care, partnering with genomic data management and analytics specialist BC Platforms earlier this year.
Genomic testing offers a more accurate diagnosis and better analysis of outcomes for cancer patients. New genomic profiling includes an updated gene list and alterations in the most commonly mutated genes known to drive the growth of cancer. New tests detail genomic signatures which can better direct treatment decisions. The service will help Bumrungrad offer specific individual cancer treatments, customised to each patient.